CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)

Clinical trial NCT03289702 · COMPLETED

Trial details

NCT number: NCT03289702
Sponsor: Medy-Tox
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Muscle Spasticity

Start date: 2017-11-13
Primary completion: 2018-06-30
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.